A Prospective Multi-center Phase III Randomized Controlled Trial

NCT02607592 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

293

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma，Non-Small-Cell Lung

Interventions

DRUG: cisplatin and pemetrexed
DRUG: nedaplatin+pemetrexed

Sponsor

Sun Yat-sen University